Homestead Advisers Corp Pfizer Inc Transaction History

Homestead Advisers Corp

$4.04 Billion
Q2 2024

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	SELL	$26.13 - $33.94 $21.7 Million - $28.2 Million	-831,100 Reduced 54.87%	683,660 $19.7 Million
Q3 2023 Nov 09, 2023	BUY	$32.09 - $37.51 $741,279 - $866,481	23,100 Added 1.55%	1,514,760 $50.2 Million
Q2 2023 Jul 25, 2023	BUY	$36.12 - $41.79 $220,331 - $254,919	6,100 Added 0.41%	1,491,660 $54.7 Million
Q1 2023 Apr 27, 2023	SELL	$39.39 - $51.28 $1.11 Million - $1.45 Million	-28,300 Reduced 1.87%	1,485,560 $60.6 Million
Q4 2022 Feb 03, 2023	BUY	$41.75 - $54.5 $83,500 - $109,000	2,000 Added 0.13%	1,513,860 $77.6 Million
Q3 2022 Nov 07, 2022	SELL	$43.76 - $53.42 $131,280 - $160,260	-3,000 Reduced 0.2%	1,511,860 $66.2 Million
Q1 2022 May 12, 2022	SELL	$45.75 - $56.69 $30.9 Million - $38.3 Million	-676,200 Reduced 30.86%	1,514,860 $78.4 Million
Q4 2021 Feb 07, 2022	SELL	$41.32 - $61.25 $648,724 - $961,625	-15,700 Reduced 0.71%	2,191,060 $129 Million
Q3 2021 Nov 05, 2021	BUY	$39.25 - $50.42 $368,950 - $473,948	9,400 Added 0.43%	2,206,760 $94.9 Million
Q2 2021 Aug 02, 2021	SELL	$35.91 - $40.68 $1.04 Million - $1.18 Million	-29,100 Reduced 1.31%	2,197,360 $86 Million
Q1 2021 May 07, 2021	SELL	$33.49 - $37.77 $6.74 Million - $7.61 Million	-201,400 Reduced 8.3%	2,226,460 $80.7 Million
Q4 2020 Feb 10, 2021	SELL	$33.47 - $42.56 $1.98 Million - $2.52 Million	-59,300 Reduced 2.38%	2,427,860 $89.4 Million
Q3 2020 Nov 13, 2020	SELL	$31.75 - $37.25 $21.6 Million - $25.3 Million	-679,400 Reduced 21.46%	2,487,160 $91.3 Million
Q2 2020 Aug 13, 2020	BUY	$30.12 - $36.54 $87,348 - $105,966	2,900 Added 0.09%	3,166,560 $104 Million
Q1 2020 May 14, 2020	SELL	$27.03 - $38.62 $3.13 Million - $4.47 Million	-115,782 Reduced 3.53%	3,163,660 $103 Million
Q4 2019 Feb 13, 2020	SELL	$32.92 - $37.36 $1.05 Million - $1.2 Million	-32,023 Reduced 0.97%	3,279,442 $128 Million
Q3 2019 Nov 14, 2019	SELL	$32.49 - $42.13 $3.69 Million - $4.78 Million	-113,535 Reduced 3.31%	3,311,465 $119 Million
Q1 2019 May 14, 2019	SELL	$37.5 - $41.2 $22.1 Million - $24.3 Million	-590,000 Reduced 14.69%	3,425,000 $145 Million
Q4 2018 Feb 13, 2019	SELL	$38.47 - $43.86 $3.85 Million - $4.39 Million	-100,000 Reduced 2.43%	4,015,000 $175 Million
Q3 2017 Nov 13, 2017	BUY	$31.0 - $34.15 $128 Million - $141 Million	4,115,000	4,115,000 $147 Million

Others Institutions Holding PFE

# of Institutions

3,218

Shares Held

3.71B

Call Options Held

73.2M

Put Options Held

108M

Vanguard Group Inc Valley Forge, PA

511M
Shares

$15.2 Billion
0.28% of portfolio
Black Rock Inc. New York, NY

424M
Shares

$12.6 Billion
0.27% of portfolio
State Street Corp Boston, MA

287M
Shares

$8.51 Billion
0.36% of portfolio
Wellington Management Group LLP Boston, MA

166M
Shares

$4.93 Billion
0.85% of portfolio
Charles Schwab Investment Management Inc San Francisco, CA

117M
Shares

$3.48 Billion
0.63% of portfolio

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $166B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Homestead Advisers Corp, based on Form 13F filings with the SEC.

News

Stay updated on Homestead Advisers Corp with notifications on news.

Account